Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Markets have further increased bets on Fed tightening and now fully price a 25bp Federal Reserve rate hike in December.
2026-11-10
Markets have further increased bets on Fed tightening and now fully price a 25bp Federal Reserve rate hike in December.
Back
Other News
2026-11-10
China A-share AI animated-drama theme extended gains as Huace Film & TV re-sealed a 20% limit-up. Earlier WenTou Holdings, Ciwen Media, Xinju Network, Tianwei Video and Yinli Media hit limit-up; Huazhi Digital Media and Baina Qiancheng rose over 10%.
China A-share AI animated-drama theme extended gains as Huace Film & TV re-sealed a 20% limit-up. Earlier WenTou Holdings, Ciwen Media, Xinju Network, Tianwei Video and Yinli Media hit limit-up; Huazhi Digital Media and Baina Qiancheng rose over 10%.
2026-11-10
China's National Health Commission, National Healthcare Security Administration, National Administration of Traditional Chinese Medicine and the CDC on the 10th issued a notice to further improve safe, rational allocation and use of innovative drugs,
China's National Health Commission, National Healthcare Security Administration, National Administration of Traditional Chinese Medicine and the CDC on the 10th issued a notice to further improve safe, rational allocation and use of innovative drugs, focusing on promoting rational allocation, strengthening training and guidance, easing use conditions and improving management. The notice directs implementation of pharmacy-related medical service pricing items, pledges enhanced support measures to optimize the policy environment for innovative drugs, states medical institutions will not be restricted on total drug varieties/specifications, and clarifies relevant innovative drugs will be excluded from public hospitals' performance-monitoring indicators, including outpatient and inpatient per‑visit drug-cost growth.
Chat with us
, powered by
LiveChat